131 related articles for article (PubMed ID: 10704894)
1. Improvement of availability of allopurinol from pharmaceutical dosage forms I - suppositories.
Samy EM; Hassan MA; Tous SS; Rhodes CT
Eur J Pharm Biopharm; 2000 Mar; 49(2):119-27. PubMed ID: 10704894
[TBL] [Abstract][Full Text] [Related]
2. Rectal bioavailability of amoxicillin sodium in rabbits: Effects of suppository base and drug dose.
Purohit TJ; Hanning SM; Amirapu S; Wu Z
J Control Release; 2021 Oct; 338():858-869. PubMed ID: 34534590
[TBL] [Abstract][Full Text] [Related]
3. Formulation development of allopurinol suppositories and injectables.
Lee DK; Wang DP
Drug Dev Ind Pharm; 1999 Nov; 25(11):1205-8. PubMed ID: 10596359
[TBL] [Abstract][Full Text] [Related]
4. Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.
Balata G; Mahdi M; Bakera RA
Indian J Pharm Sci; 2011 Sep; 73(5):517-26. PubMed ID: 22923864
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
Balakrishnan P; Song CK; Cho HJ; Yang SG; Kim DD; Yong CS; Choi HG
Arch Pharm Res; 2012 Jul; 35(7):1169-75. PubMed ID: 22864739
[TBL] [Abstract][Full Text] [Related]
6. Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.
Zidan AS; Emam SE; Shehata TM; Ghazy FE
AAPS PharmSciTech; 2015 Jun; 16(3):645-55. PubMed ID: 25501871
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of allopurinol oral and rectal dosage forms.
Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inclusion complexation of decanoic acid with alpha-cyclodextrin on rectal absorption of cefmetazole sodium suppository in rabbits].
Yanagi H; Ishikura N; Kenmotsu H; Yagi N; Goto K; Kato S; Sumiya S; Takada M
Yakugaku Zasshi; 1991 Jan; 111(1):65-9. PubMed ID: 2056446
[TBL] [Abstract][Full Text] [Related]
9. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
Onyeji CO; Adebayo AS; Babalola CP
Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
[TBL] [Abstract][Full Text] [Related]
10. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis.
Dash AK; Gong Z; Miller DW; Huai-Yan H; Laforet J
Int J Pharm; 1999 Nov; 190(1):21-34. PubMed ID: 10528093
[TBL] [Abstract][Full Text] [Related]
11. Relative hypoglycemic effect of insulin suppositories in diabetic beagle dogs: optimization of various concentrations of sodium salicylate and polyoxyethylene-9-lauryl ether.
Hosny EA; Al-Shora HI; Elmazar MM
Biol Pharm Bull; 2001 Nov; 24(11):1294-7. PubMed ID: 11725967
[TBL] [Abstract][Full Text] [Related]
12. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
Yun M; Choi H; Jung J; Kim C
Int J Pharm; 1999 Nov; 189(2):137-45. PubMed ID: 10536242
[TBL] [Abstract][Full Text] [Related]
13. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
Celebi N; Iscanoglu M; Degim T
Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
[TBL] [Abstract][Full Text] [Related]
14. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
15. Rectal absorption enhancement of gentamicin in rabbits from hollow type suppositories by sodium salicylate or sodium caprylate.
Matsumoto Y; Watanabe Y; Tojima T; Murakoshi R; Murakami C; Matsumoto M
Drug Des Deliv; 1989 May; 4(3):247-56. PubMed ID: 2490276
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
[TBL] [Abstract][Full Text] [Related]
17. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
18. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties.
Dash AK; Cudworth GC
AAPS PharmSciTech; 2001 Jul; 2(3):E13. PubMed ID: 14727872
[TBL] [Abstract][Full Text] [Related]
20. Polymer-free and polyvinylpirrolidone-based electrospun solid dosage forms for drug dissolution enhancement.
Vigh T; Horváthová T; Balogh A; Sóti PL; Drávavölgyi G; Nagy ZK; Marosi G
Eur J Pharm Sci; 2013 Jul; 49(4):595-602. PubMed ID: 23684933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
